Physiomics Share Discussion Threads

[the stigologist] 06/4/2018 14:47

PYC £3m (Physiomics - AIM)
SLP $300m (Simulations Plus - Nasdaq)
CER $850m (Certara - Private)

[the stigologist] 06/4/2018 14:44

These shares are going to be worth 100p+ and pretty soon i reckon

The plebs here obviously have no idea what is coming

[hazelst] 06/4/2018 14:36

Looking good!

[spacedust] 06/4/2018 12:41

Ok I will chill. I am watching this.....just unbelievable

[buffskins] 06/4/2018 12:14

chill spaceboy

[spacedust] 06/4/2018 12:10

Couple of tick ups.....givimg dogs some bone to lick

[spacedust] 05/4/2018 17:55

Some people will defend the company and say that share price is being controlled below 5p to get sellers as there is some invisible buyer in the background.

Placing consolidation rinse repeat. Spikes here and there. Story of the game. And why not been a success in risning for 15yrs so why stop such a brilliant mechanism.

Wakners!!!!

[spacedust] 05/4/2018 15:42

You did hence my reference
pwhite the great
Jim the wakner
Founder the wakner

[pwhite73] 05/4/2018 13:54

When I told you all this was heading for 2p you all laughed. Some are still laughing. All that is happening is that the MM are pushing through 2p placing shares at prices all the way down from 32p. Nothing has changed with this company. Buy for 5p at your peril.

[spacedust] 05/4/2018 13:20

Go on stig filter me. See what difference it makes

[spacedust] 05/4/2018 13:20

The bottom culd be anything down to 0p.

Jim the wakner
Founderthe wakner

[spacedust] 05/4/2018 13:19

Spacedust (filtered)

[spacedust] 05/4/2018 13:18

The Stigologist

27 Mar '18 - 20:07 - 2243 of 2280

Excellent options RNS

Sets 5.35p as new base price

Jim Millen will be millionaire at 50p

Will be multimillionaire at 100p+

I think he deserves to be multimultimillionaire at 1000p

[spacedust] 05/4/2018 13:16

Who was it that said 5.35p now the bottom???? There it is 4.95p. Next stop anyone?

Losing so much money on this pile of junk of a share

[spacedust] 05/4/2018 12:59

And the founder thinks this is is devalued even at 100p!!! But does t buy any either.

If you were offered a sports car worth 100k for 5k would you not purchase it???

[spacedust] 05/4/2018 12:58

But the CEO is confident and shows his confidence by not purchasing any shares

[buffskins] 05/4/2018 12:28

I hate this effing share !!!

[spacedust] 05/4/2018 12:27

And share price saying otherwise.....back to 4.9p

[spacedust] 05/4/2018 12:27

Can't see no rns

[billthebank] 04/4/2018 08:55

We believe that the signing of agreements with three major pharmaceutical clients within the space of three months is a real sign of the confidence in our technology that is starting to build within the industry. Our aim now will be to develop longer-term relationships with these major companies and to secure further pre-clinical and clinical projects.�

[the stigologist] 04/4/2018 08:33

Excellent RNS

"Physiomics believes that the conference represents an excellent opportunity to showcase its capabilities, and will be sending a team of three, including CEO Dr Jim Millen. The Company will host a booth in the main meeting hall as well as present the results of its recently completed Innovate UK funded research project on the personalised treatment of oesophageal cancer. The Company plans to use the opportunity of the conference to touch base with current clients, all of whom will be represented there, as well as to hold targeted meetings with potential future clients."

[margic] 31/3/2018 12:02

More of an airways man myself, 4-5 a time to get that burn!

[pwhite73] 29/3/2018 23:42

The embargoed news due for release are the results from the Innovate UK 2017 grant project completed in February 2018. They told you this in RNS 12/03/2018. They even told you what the project was about.

RNS 12/03/2018 - "The project 'Decision Support System For Stratified Cancer Treatment' analysed data from over 400 oesophageal cancer patients to determine patient and disease specific factors that could help guide treatment to achieve the best outcomes".

If this company's history on personalised medicine is anything to go by you should expect the embargoed news to be something along the lines of "Tunes help you breathe more easily".